AB
PTGX icon

Amalgamated Bank’s Protagonist Therapeutics PTGX Stock Holding History

Amalgamated Bank’s Portfolio PTGX Stock Details PTGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.99M Sell
16,268
-584
-3% -$61K 0.01% 835
2026
Q1 		$1.78M Sell
16,852
-211
-1% -$18.7K 0.01% 857
2025
Q4 		$1.49M Buy
17,063
+237
+1% +$19.4K 0.01% 929
2025
Q3 		$1.12M Sell
16,826
-717
-4% -$40.8K 0.01% 1028
2025
Q2 		$970K Buy
17,543
+605
+4% +$29K 0.01% 1052
2025
Q1 		$819K Sell
16,938
-467
-3% -$19.6K 0.01% 1098
2024
Q4 		$672K Buy
17,405
+81
+0.5% +$3.53K 0.01% 1198
2024
Q3 		$780K Buy
17,324
+15,301
+756% +$618K 0.01% 1139
2024
Q2 		$70K Buy
2,023
+74
+4% +$2.17K ﹤0.01% 1789
2024
Q1 		$56K Sell
1,949
-4,912
-72% -$134K ﹤0.01% 1842
2023
Q4 		$157K Buy
6,861
+100
+1% +$1.75K ﹤0.01% 1870
2023
Q3 		$113K Hold
6,761
– – ﹤0.01% 1957
2023
Q2 		$187K Buy
6,761
+2,032
+43% +$50.9K ﹤0.01% 1841
2023
Q1 		$109K Sell
4,729
-1,036
-18% -$17.4K ﹤0.01% 2025
2022
Q4 		$63K Hold
5,765
– – ﹤0.01% 2326
2022
Q3 		$49K Hold
5,765
– – ﹤0.01% 2471
2022
Q2 		$46K Sell
5,765
-1,530
-21% -$18.5K ﹤0.01% 2531
2022
Q1 		$173K Sell
7,295
-584
-7% -$16.5K ﹤0.01% 1995
2021
Q4 		$269K Buy
+7,879
New +$249K ﹤0.01% 1868
2021
Q3 		– Sell
-7,807
Closed -$350K – 2177
2021
Q2 		$350K Buy
+7,807
New +$258K ﹤0.01% 1810

Other funds holding PTGX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM

Amalgamated Bank's PTGX Position: Q2 2026 in Review

Amalgamated Bank reduced its Protagonist Therapeutics (PTGX) stake by 3.5% in Q2 2026, selling an estimated $61K and leaving 16,268 shares worth $1.99M. The position accounts for 0.01% of the portfolio, ranked #835.

Amalgamated Bank first reported a position in PTGX in Q2 2021 and has held it in 20 quarters since. 143 funds tracked by Wall St. Rank hold PTGX as of Q2 2026.

  • Amalgamated Bank held 16,268 shares of Protagonist Therapeutics worth $1.99M as of Q2 2026.
  • Amalgamated Bank sold 584 Protagonist Therapeutics shares in Q2 2026, an estimated $61K.
  • Protagonist Therapeutics made up 0.01% of Amalgamated Bank's portfolio in Q2 2026, its #835 holding.
  • Amalgamated Bank first reported a position in Protagonist Therapeutics in Q2 2021 and has held it in 20 quarters since.
  • 143 funds tracked by Wall St. Rank held Protagonist Therapeutics as of Q2 2026.

Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.